Switzerland · Delayed Price · Currency is CHF medmix AG Statistics
Total Valuation
medmix AG has a market cap or net worth of CHF 362.80 million. The enterprise value is 590.40 million.
| Market Cap | 362.80M |
| Enterprise Value | 590.40M |
Important Dates
The last earnings date was Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | Apr 25, 2025 |
Share Statistics
medmix AG has 40.67 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 40.67M |
| Shares Outstanding | 40.67M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | -2.24% |
| Owned by Insiders (%) | 41.26% |
| Owned by Institutions (%) | 21.53% |
| Float | 23.89M |
Valuation Ratios
The trailing PE ratio is 59.47 and the forward PE ratio is 16.71. medmix AG's PEG ratio is 0.42.
| PE Ratio | 59.47 |
| Forward PE | 16.71 |
| PS Ratio | 0.81 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 6.50 |
| P/FCF Ratio | 10.89 |
| P/OCF Ratio | 5.35 |
| PEG Ratio | 0.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.17, with an EV/FCF ratio of 17.73.
| EV / Earnings | 92.25 |
| EV / Sales | 1.32 |
| EV / EBITDA | 7.17 |
| EV / EBIT | 20.36 |
| EV / FCF | 17.73 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.54 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 4.06 |
| Debt / FCF | 10.04 |
| Interest Coverage | 2.71 |
Financial Efficiency
Return on equity (ROE) is 1.59% and return on invested capital (ROIC) is 3.49%.
| Return on Equity (ROE) | 1.59% |
| Return on Assets (ROA) | 1.90% |
| Return on Invested Capital (ROIC) | 3.49% |
| Return on Capital Employed (ROCE) | 3.70% |
| Weighted Average Cost of Capital (WACC) | 5.88% |
| Revenue Per Employee | 167,979 |
| Profits Per Employee | 2,400 |
| Employee Count | 2,667 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 3.82 |
Taxes
In the past 12 months, medmix AG has paid 1.90 million in taxes.
| Income Tax | 1.90M |
| Effective Tax Rate | 21.35% |
Stock Price Statistics
The stock price has decreased by -14.23% in the last 52 weeks. The beta is 0.86, so medmix AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -14.23% |
| 50-Day Moving Average | 11.11 |
| 200-Day Moving Average | 10.61 |
| Relative Strength Index (RSI) | 22.43 |
| Average Volume (20 Days) | 97,246 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, medmix AG had revenue of CHF 448.00 million and earned 6.40 million in profits. Earnings per share was 0.15.
| Revenue | 448.00M |
| Gross Profit | 161.90M |
| Operating Income | 29.00M |
| Pretax Income | 8.90M |
| Net Income | 6.40M |
| EBITDA | 72.90M |
| EBIT | 29.00M |
| Earnings Per Share (EPS) | 0.15 |
Balance Sheet
The company has 113.90 million in cash and 334.40 million in debt, with a net cash position of -220.50 million or -5.42 per share.
| Cash & Cash Equivalents | 113.90M |
| Total Debt | 334.40M |
| Net Cash | -220.50M |
| Net Cash Per Share | -5.42 |
| Equity (Book Value) | 432.80M |
| Book Value Per Share | 10.47 |
| Working Capital | 93.40M |
Cash Flow
In the last 12 months, operating cash flow was 67.80 million and capital expenditures -34.50 million, giving a free cash flow of 33.30 million.
| Operating Cash Flow | 67.80M |
| Capital Expenditures | -34.50M |
| Free Cash Flow | 33.30M |
| FCF Per Share | 0.82 |
Margins
Gross margin is 36.14%, with operating and profit margins of 6.47% and 1.43%.
| Gross Margin | 36.14% |
| Operating Margin | 6.47% |
| Pretax Margin | 1.99% |
| Profit Margin | 1.43% |
| EBITDA Margin | 16.27% |
| EBIT Margin | 6.47% |
| FCF Margin | 7.43% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.14%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 1.14% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 234.38% |
| Buyback Yield | -0.25% |
| Shareholder Yield | 0.89% |
| Earnings Yield | 1.76% |
| FCF Yield | 9.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
medmix AG has an Altman Z-Score of 1.91 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.91 |
| Piotroski F-Score | 5 |